Request Appointment
1275 York AvenueNew York, NY 10065
Overview of Dr. Beal
Dr. Kathryn Beal is a radiation oncologist in New York, NY and is affiliated with New York-Presbyterian Hospital. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 26 years. Dr. Beal accepts several types of health insurance, listed below. She is one of 82 doctors at New York-Presbyterian Hospital who specialize in Radiation Oncology. She has more than 100 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2001 - 2005
Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalInternship, Internal Medicine, 2000 - 2001
Columbia University Vagelos College of Physicians and SurgeonsClass of 2000
Certifications & Licensure
FL State Medical License 2024 - Present
NY State Medical License 2002 - 2028
NJ State Medical License 2021 - 2027
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
Clinical Trials
- Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases Start of enrollment: 2004 Jun 01
- Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy. Start of enrollment: 2008 Nov 01
- Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis Start of enrollment: 2013 Oct 25
Publications & Presentations
PubMed
- 1 citationsClinical Utility of [F]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma.Jana Ivanidze, Kellen Vo Vu, Rongwei Fu, Andrew Brandmaier, Laszlo Szidonya
AJNR. American Journal of Neuroradiology. 2026-06-03 - [68Ga]-DOTATATE PET SUV Reduction After Bevacizumab in High-Grade Meningioma: A Potential Treatment Response Biomarker.Kellen Vo Vu, Hannah G Otis, Andrew Brandmaier, Joseph R Osborne, Philip E Stieg
AJNR. American Journal of Neuroradiology. 2026-02-23 - Clinical experience with a same-day simulation and treatment program for stereotactic radiation therapy on a C-arm linac.Michalis Aristophanous, Sernger Shen, Dylan G Hsu, Dongxu Wang, Ase Ballangrud
Journal of Applied Clinical Medical Physics. 2026-01-01
Journal Articles
- Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients with CancerMorgan E Freret, Robin H Unger, Kathryn Beal, Suzanne L Wolden, JAMA Dermatology
- Melanoma Brain Metastases Treated with Stereotactic Radiosurgery and Concurrent Pembrolizumab Display Marked Regression; Efficacy and Safety of Combined TreatmentJedd D Wolchok, Kathryn Beal, Yoshiya Yamada, Michael A Postow, BioMed Central
Authored Content
- Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients with CancerAugust 2020
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPOMultiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United - River Valley Neighborhood Health Partnership
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
